Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCPK:AGRX)

Agile Therapeutics Announces Issuance of Patent for Twirla(R) Patch Design

GlobeNewswire June 12, 2015

Agile Therapeutics to Present at the William Blair 35th Annual Growth Stock Conference

GlobeNewswire May 28, 2015

Agile Therapeutics Reports First Quarter Financial Results

GlobeNewswire May 12, 2015

Agile Therapeutics to Present at the 14th Annual Needham Healthcare Conference

GlobeNewswire April 7, 2015

Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results

GlobeNewswire March 26, 2015

Agile Therapeutics to Present at the 27th Annual ROTH Conference

GlobeNewswire March 2, 2015

Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial

GlobeNewswire February 24, 2015

Agile Therapeutics to Present at the 2015 RBC Capital Markets' Global Healthcare Conference

GlobeNewswire February 12, 2015

Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update

GlobeNewswire January 20, 2015

Agile Therapeutics to Present at Noble Financial Capital Markets' Eleventh Annual Equity Conference

GlobeNewswire January 6, 2015

Agile Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 22, 2014

Agile Therapeutics Announces Publication of Data on Low-Dose Investigational Contraceptive Patch

GlobeNewswire December 1, 2014

Agile Therapeutics Appoints John Hubbard, Ph.D., FCP to Its Board of Directors

GlobeNewswire November 18, 2014

Agile Therapeutics Reports Third Quarter 2014 Financial Results

GlobeNewswire November 13, 2014

Agile Therapeutics Appoints James P. Tursi, M.D. to Its Board of Directors

GlobeNewswire October 1, 2014

Agile Announces Dosing of First Patients in Twirla(R) Phase 3 SECURE Study

GlobeNewswire September 29, 2014

Agile to Present at the 21st Annual BioCentury NewsMakers Conference

GlobeNewswire September 22, 2014

Agile Initiates Phase 3 SECURE Study for Twirla(TM)

GlobeNewswire September 16, 2014

Agile Therapeutics to Ring the NASDAQ Stock Market Closing Bell

GlobeNewswire September 2, 2014

Agile Therapeutics, Inc. (NASDAQ: AGRX) to Ring the NASDAQ Stock Market Closing Bell

GlobeNewswire August 29, 2014